Dublin, April 06, 2020 (GLOBE NEWSWIRE) -- The "U.S. Patient Monitoring Devices Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
Patient monitoring devices provide assistance in continuous measurement of a patient's health parameter such as heart rate, respiratory rate, blood pressure, blood oxygen saturation and many other parameters which has become a common feature of all healthcare settings. The U.S. Patient monitoring market is is expected to reach $13,110.7 million by 2026 growing at low single digit CAGR.
The increase in the rate of surgeries and diseased population requires continuous monitoring, increasing demand for portable and remote patient monitoring and increasing funding and investment in patient monitoring are driving the market growth. However, the high cost of patient monitoring devices, stringent regulatory approvals for products, Patient safety and inaccuracy concerns associated with patient monitoring devices, increased product recalls are restraining the market growth.
Medtronic PLC (Ireland), Dexcom Inc. (U.S.), Masimo Corporation (Switzerland), Abbott Laboratories (U.S.), BioTelemetry Inc. (U.S.), Edwards Lifesciences Corporation (U.S.), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Hill-Rom Holdings, Inc. (U.S.), Natus medical incorporated (U.S.), iRhythm Technologies, Inc (U.S.) and Dragerwerk AG & Co. KGaA (Germany).
Key Topics Covered:
1 Executive Summary
2 Introduction
2.1 Key Takeaways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Breakdown and Data Triangulation
2.5.3 Secondary Sources
2.5.4 Primary Sources
2.5.5 Key Data Points from Secondary Sources
2.5.6 Key Data Points from Primary Sources
2.5.7 Assumptions
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increase in the Rate of Surgeries and Diseased Population Require Continuous Monitoring.
3.3.1.2 Increasing Demand for Portable and Remote Patient Monitoring Devices.
3.3.1.3 Increasing Funding and Investment in Patient Monitoring
3.3.1.4 Favorable Reimbursement Policies
3.3.1.5 Technological Advancements
3.3.2 Restraints and Threats
3.3.2.1 The High Cost of Patient Monitoring Devices
3.3.2.2 Patient Safety and Inaccuracy Concern Associated With Patient Monitoring Devices
3.3.2.3 Increased Product Recalls
3.3.2.4 Lack of Cyber-Security in Wireless Patient Monitoring Devices
3.3.2.5 Stringent Regulatory Requirements for New Products
3.4 Regulatory Affairs
3.4.1 International Organization for Standardization
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 Iso 13485 Medical Devices
3.4.2 The U.S.
3.5 Technological Advancements
3.5.1 Biosticker
3.5.2 Artificial Intelligence in Patient Monitoring Devices
3.5.3 Wearable Patient Monitoring Devices
3.5.4 IoT in Patient Monitoring System
3.5.5 Home Dialysis Remote Patient Monitoring System
3.6 Porter's Five Force Analysis
3.7 Supply Chain Analysis
3.8 Clinical Trials
3.9 Market Share Analysis
3.10 Patient Monitoring Devices Number of Units Sold and Installed Base
4 Patient Monitoring Devices Market, by Devices
4.1 Introduction
4.2 Neuromonitoring Devices
4.2.1 Electroencephalograph (EEG)
4.2.2 Cerebral Oximeter
4.2.3 Intracranial Pressure Monitors (ICP)
4.2.4 Magnetoencephalograph (MEG)
4.2.5 Electromyograph Machines (EMG)
4.3 Hemodynamic Monitoring Devices
4.3.1 Blood Pressure Monitors
4.3.2 Cardiac Output Monitoring
4.4 Blood Glucose Monitors
4.4.1 Self Blood Glucose Monitoring (SBGM)
4.4.2 Continuous Glucose Monitoring (CGM)
4.5 Cardiac Monitoring Devices
4.5.1 12-Leads Ecg Monitors
4.5.2 Event Monitors
4.5.3 Holter Monitors
4.6 Fetal and Neonatal Care Monitoring Devices
4.6.1 Fetal Monitors
4.6.2 Fetal Dopplers
4.6.3 Infant Incubators
4.6.4 Neonatal Monitoring Devices
4.7 Respiratory Monitoring Devices
4.7.1 Capnography
4.7.2 Spirometer
4.7.3 Anesthesia Monitors
4.7.4 Polysomnography Devices
4.7.5 Pulse Oximeters
4.7.5.1 Fingertip Pulse Oximeters
4.7.5.2 Handheld Pulse Oximeters
4.7.5.3 Tabletop Pulse Oximeters
4.7.5.4 Other Pulse Oximeters
4.7.6 Other Respiratory Devices
4.8 Multi-Parameter Monitoring Devices
4.8.1 High-Acuity
4.8.2 Mid-Acuity
4.8.3 Low-Acuity
4.9 Temperature Monitoring Devices
4.9.1 Digital Thermometers
4.9.2 Infrared Thermometers (IR Thermometers)
4.9.3 Others (Thermometer Strips)
4.10 Remote Patient Monitoring Devices (RPM)
4.10.1 Remote Neuromonitoring Devices
4.10.2 Remote Hemodynamic Monitoring Devices
4.10.3 Remote Cardiac Monitoring Devices
4.10.3.1 Implantable Loop Recorder
4.10.3.2 Mobile Cardiac Telemetry (MCT/MCOT)
4.10.4 Remote Multi-Parameter Monitoring Devices
4.10.5 Other Remote Monitoring Devices
5 Patient Monitoring Devices Market, by Portability
5.1 Introduction
5.2 Stationary Patient Monitoring Devices
5.3 Portable Patient Monitoring Devices
5.4 Wearable Patient Monitoring Devices
5.5 Implantable Patient Monitoring Devices
6 Patient Monitoring U.S. Market, by End-Users
6.1 Introduction
6.2 Hospitals
6.3 Ambulatory Surgical Centers
6.4 Home Healthcare
6.5 Others (Sleep Centers, Clinics/Physician Offices, Hospices)
7 Competitive Landscape
7.1 Introduction
7.2 Approvals
7.3 New Product Launch
7.4 Agreements, Partnership and Collaboration
7.5 Acquisition
8 Major Player Profiles
8.1 Abbott Laboratories
8.2 Bio Telemetry Inc
8.3 Dexcom, Inc
8.4 Edwards Lifesciences Corporation.
8.5 GE Healthcare
8.6 Hill-Rom Holdings, Inc.
8.7 Irhythm Technologies, Inc.
8.8 Koninklijke Philips N.V.
8.9 Masimo Corporation
8.10 Medtronic, Plc
8.11 Natus Medical Incorporated.
8.12 Omron Corporation
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/jvg30d
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900